NFKB1 and urinary bladder cancer: BAY11-7082, an inhibitor of the NF-κB pathway, effectively reduces the invasiveness of bladder cancer cells and prevents the M2 polarization of TAMs, highlighting its role in macrophage polarization and its potential in modulating tumor microenvironments (Zhang et al., 2019).